3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma
550
Precursor Cell Lymphoblastic Leukemia-Lymphoma
509
Lymphoma, Non-Hodgkin
439
Lymphoma, Follicular
407
Lymphoma, Large B-Cell, Diffuse
391
Leukemia, Lymphocytic, Chronic, B-Cell
391
Lymphoma, B-Cell
248
Lymphoma, Mantle-Cell
224
Hodgkin Disease
209
Recurrence
204
Leukemia, Myeloid, Acute
198
Leukemia
197
Multiple Myeloma
186
Burkitt Lymphoma
184
Lymphoma, B-Cell, Marginal Zone
170
Neoplasms
153
Myelodysplastic Syndromes
133
Hematologic Neoplasms
115
Waldenstrom Macroglobulinemia
103
Lymphoma, T-Cell, Peripheral
86
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
83
Lymphoma, T-Cell
82
Lymphoma, T-Cell, Cutaneous
67
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
63
Mycosis Fungoides
57
Leukemia, Biphenotypic, Acute
55
Breast Neoplasms
55
Leukemia, B-Cell
52
Myeloproliferative Disorders
50
Lymphoproliferative Disorders
47
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pneumococcal Infections
×
Lymphoid
×
1 year
×
Clear all
NCT04214444
2026-02-12
EVAPOR
University Hospital, Tours
Phase 3
Completed
26 enrolled